Literature DB >> 10190169

A model for the origins and spread of drug-resistant malaria.

I M Hastings1.   

Abstract

A general method of investigating parasite population genetics is presented and used to investigate the evolution of drug resistance in Plasmodium. The most important biological factor is the nature of the control, presumably through host immunity, of the malarial infection. Two models are examined: a 'generalized immunity' (GI) model in which immunity regulates the overall level of infection, and a 'specific immunity' (SI) model in which each clone within the infection is regulated independently. These models are used to investigate 3 critical factors in the evolution of resistance: (i) the frequency of resistant alleles in the population prior to drug use, (ii) the dynamics of resistance following drug application and (iii) the magnitude of threshold frequencies below which resistance will not evolve. These analyses also identify the implicit assumptions made in several previous models, reconcile their differing conclusions and allow a more informed debate about the practical application of drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10190169     DOI: 10.1017/s0031182097001261

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  48 in total

1.  Antimalarial drugs clear resistant parasites from partially immune hosts.

Authors:  P Cravo; R Culleton; P Hunt; D Walliker; M J Mackinnon
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 2.  The evolution of drug-resistant malaria: the role of drug elimination half-life.

Authors:  Ian M Hastings; William M Watkins; Nicholas J White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 3.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

4.  Superinfection and the evolution of resistance to antimalarial drugs.

Authors:  Eili Y Klein; David L Smith; Ramanan Laxminarayan; Simon Levin
Journal:  Proc Biol Sci       Date:  2012-07-11       Impact factor: 5.349

5.  Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Authors:  Silvie Huijben; William A Nelson; Andrew R Wargo; Derek G Sim; Damien R Drew; Andrew F Read
Journal:  Evolution       Date:  2010-08-19       Impact factor: 3.694

6.  Benefits of using multiple first-line therapies against malaria.

Authors:  Maciej F Boni; David L Smith; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

7.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

8.  "Clonal" population structure of the malaria agent Plasmodium falciparum in high-infection regions.

Authors:  F G Razakandrainibe; P Durand; J C Koella; T De Meeüs; F Rousset; F J Ayala; F Renaud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

9.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

10.  Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.

Authors:  Rashad Abdul-Ghani; Hoda F Farag; Amal F Allam; Ahmed A Azazy
Journal:  Parasitol Res       Date:  2014-02-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.